Last update 08 May 2025

Etoricoxib/Betamethasone

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
COX-2 x GR
Action
inhibitors, agonists
Mechanism
COX-2 inhibitors(Cyclooxygenase-2 inhibitors), GR agonists(Glucocorticoid receptor agonists)
Therapeutic Areas
Immune System DiseasesCongenital DisordersEndocrinology and Metabolic Disease+ [2]
Active Indication
Arthritis, GoutyPrimary gout
Inactive Indication-
Originator Organization
Laboratorios Silanes SA de CVLaboratorios Silanes SA de CV
Active Organization
Laboratorios Silanes SA de CVLaboratorios Silanes SA de CV
Inactive Organization-
License Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Etoricoxib/Betamethasone
NCT06863701
/ RecruitingPhase 3
Efficacy and Safety Study for the Combination of Etoricoxib / Betamethasone Compared to Etoricoxib for the Treatment of Patients Diagnosed With Acute Gout Arthritis
100 Clinical Results associated with Etoricoxib/Betamethasone
Login to view more data
100 Translational Medicine associated with Etoricoxib/Betamethasone
Login to view more data
100 Patents (Medical) associated with Etoricoxib/Betamethasone
Login to view more data
100 Deals associated with Etoricoxib/Betamethasone
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Arthritis, GoutyPhase 3
Mexico
Laboratorios Silanes SA de CVLaboratorios Silanes SA de CV
27 Jan 2025
Primary goutPhase 3
Mexico
Laboratorios Silanes SA de CVLaboratorios Silanes SA de CV
27 Jan 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free